Neurocysticercosis: Local and systemic immune-inflammatory features related to severity

Medical Microbiology and Immunology

Volumn 201, Issue 1, 2012, Pages 73-80

  Sáenz, Brenda ^a   Fleury, Agnes ^a,b   Chavarría, Anahí ^c   Hernández, Marisela ^a   Crispin, José C ^d   Vargas Rojas, María I ^e   Fragoso, Gladis ^a   Sciutto, Edda ^a,f  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d HARVARD MEDICAL SCHOOL   (United States)

^e INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^f INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

Immune response; Neurocysticercosis; Neuroinflammation; Taenia solium

Indexed keywords

CASPASE 3; CASPASE 8; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; CYTOKINE; IL5 PROTEIN, HUMAN;

ARTICLE; CELL COUNT; CELL PROLIFERATION; CELL STIMULATION; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROCYSTICERCOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SUPERNATANT; ANIMAL; CYSTICERCUS; HOSPITALIZATION; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; METABOLISM; MONONUCLEAR CELL; PATHOGENICITY; PATHOPHYSIOLOGY; TAENIA SOLIUM;

ANIMALS; CYSTICERCUS; CYTOKINES; FEMALE; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; MALE; NEUROCYSTICERCOSIS; SEVERITY OF ILLNESS INDEX; TAENIA SOLIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860585012     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-011-0207-0     Document Type: Article

References (41)

1. Del Brutto OH, Sotelo J (1988) Neurocystiercosis: an update. Rev Infect Dis 10:1075-1087
2. Fleury A, Dessein A, Preux PM, Dumas M, Tapia G, Larralde C, Sciutto E (2004) Symptomatic human neurocysticercosis-age, sex and exposure factors relating with disease heterogeneity. J Neurol 251(7):830-837
3. Sciutto E, Chavarria A, Fragoso G, Fleury A, Larralde C (2007) The immune response in Taenia solium cysticercosis: protection and injury. Parasite Immunol 29(12):621-636
4. Villagran J, Olvera J (1988) A clinical and pathological study of 481 autopsy cases. Patología (México) 26:149-156
5. Fleury A, Gomez T, Alvarez I, Meza D, Huerta M, Chavarria A, Carrillo-Mezo RA, Lloyd C, Dessein A, Preux PM, Dumas M, Larralde C, Sciutto E, Fragoso G (2003) High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiol 22(2):139-145
6. Sánchez AL, Lindbäck J, Schantz PM, Sone M, Sakai H, Medina MT, Ljungström I (1999) A population-based, case-control study of Taenia solium taeniasis and cysticercosis. Ann Trop Med Parasitol 93(3):247-258
7. Sáenz B, Ruíz-Garcia M, Jiménez E, Hernández-Aguilar J, Suastegui R, Larralde C, Sciutto E, Fleury A (2006) Neurocysticercosis: clinical, radiologic, and inflammatory differences between children and adults. Pediatr Infect Dis J 25(9):801-803
8. Singhi P, Singhi S (2004) Neurocysticercosis in children. J Child Neurol 19(7):482-492
9. Aguilar-Rebolledo F, Cedillo-Rivera R, Llaguno-Violante P, Torres-López J, Muñoz-Hernández O, Enciso-Moreno JA (2001) Interleukin levels in cerebrospinal fiuid from children with neurocysticercosis. Am J Trop Med Hyg 64(1-2):35-40
10. Bueno EC, Vaz AJ, Machado LR, Livramento JA, Avila SL, Ferreira AW (2001) Antigen-specific suppression of cultured lymphocytes from patients with neurocysticercosis. Clin Exp Immunol 126(2):304-310
11. Bueno EC, dos Ramos Machado L, Livramento JA, Vaz AJ (2004) Cellular immune response of patients with neurocysticercosis (inflammatory and non-inflammatory phases). Acta Trop 91(2):205-213
12. Chavarría A, Fleury A, Garcia E, Marquez C, Fragoso G, Sciutto E (2005) Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles. Clin Immunol 116(3):271-278
13. Grewal JS, Kaur S, Bhatti G, Sawhney IM, Ganguly NK, Mahajan RC, Malla N (2000) Cellular immune responses in human neurocysticercosis. Parasitol Res 86(6):500-503
14. Medina-Escutia E, Morales-Lopez Z, Proano JV, Vazquez J, Bermudez V, Navarrete VO, Madrid-Marina V, Laclette JP, Correa D (2001) Cellular immune response and Th1/Th2 cytokines in human neurocysticercosis: lack of immune suppression. J Parasitol 87:587-590
15. Restrepo BI, Aguilar MI, Melby PC, Teale JM (2001) Analysis of the peripheral immune response in patients with neurocysticercosis: evidence for T cell reactivity to parasite glycoprotein and vesicular fluid antigens. Am J Trop Med Hyg 65(4):366-370
16. Restrepo BI, Alvarez JI, Castano JA, Arias LF, Restrepo M, Trujillo J, Colegial CH, Teale JM (2001) Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect Immun 69(7):4554-4560
17. Rolfs A, Muhlschlegel F, Jansen-Rosseck R, Martins AR, Bedaque EA, Tamburus WM, Pedretti L, Schult G, Feldmeier H, Kremsner P (1995) Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. Neurology 45(3 Pt 1):532-538
18. Chavarría A, Fleury A, Bobes R, Morales J, Fragoso G, Sciutto E (2006) A depressed peripheral cellular immune response is related with symptomatic neurocysticercosis. Microbes Infect 8(4):1082-1089
19. Evans CA, Garcia HH, Hartnell A, Gilman RH, Jose PJ, Martinez M, Remick DG, Williams TJ, Friedland JS (1998) Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Infect Immun 66:4522-4525
20. Rodrigues V Jr, de-Mello FA, Magalhaes EP, Ribeiro SB, Marquez JO (2000) Interleukin-5 and interleukin-10 are major cytokines in cerebrospinal fiuid from patients with active neurocysticercosis. Braz J Med Biol Res 33(9):1059-1063
21. Chavarría A, Roger B, Fragoso G, Tapia G, Fleury A, Dumas M, Dessein A, Larralde C, Sciutto E (2003) TH2 profile in asymptomatic Taenia solium human neurocysticercosis. Microbes Infect 5(12):1109-1115
22. Rosas N, Sotelo J, Nieto D (1986) ELISA in the diagnosis of neurocysticercosis. Arch Neurol 43:353-356
23. Gaur U, Aggarwal BB (2003) Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 66(8):1403-1408
24. Pott MC, Tarelli R, Ferrari CC, Sarchi MI, Pitossi FJ (2008) Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 131(7):1880-1894
25. Taoufik Y, de Herve MG, Giron-Michel J, Durali D, Cazes E, Tardieu M, Azzarone B, Delfraissy JF et al (2001) Human microglial cells express a functional IL-12 receptor and produce IL-12 following IL-12 stimulation. Eur J Immunol 31:3228-3239
26. Lotz M, Jirik F, Kabouridis P, Tsoukas C, Hirano T, Kishimoto T, Carson DA (1998) B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med 167:1253-1258
27. Ghaffar O, Lavigne F, Kamil A, Renzi P, Hamid Q (1998) Interleukin-6 expression in chronic sinusitis: colocalization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells. Otolaryngol Head Neck Surg 118(4):504-511
28. Karlen S, De Boer ML, Lipscombe RJ, Lutz W, Mordvinov VA, Sanderson CJ (1998) Biological and molecular characteristics of interleukin-5 and its receptor. Int Rev Immunol 16(3-4):227-247
29. Oukka M (2008) Th17 cells in immunity and autoimmunity. Ann Rheum Dis 67(Suppl 3):iii26-9M
30. Aloisi F, Ambrosini E, Columba-Cabezas S, Magliozzi R, Serafini B (2001) Intracerebral regulation of immune responses. Ann Med 33(8):510-515
31. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, Dantzer R, Kelley KW (2001) Interleukin-10 in the brain. Crit Rev Immunol 21(5):427-449
32. Tiemessen MM, Kunzmann S, Schmidt-Weber CB, Garssen J, Bruijnzeel-Koomen CA, Knol EF, van Hoffen E (2003) Transforming growth factor-beta inhibits human antigen-specific CD4 + T cell proliferation. Int Immunol 15(12):1495-1504
33. Vitkovic L, Maeda S, Sternberg E (2001) Anti-inflammatory cytokines: expression and action in the brain. Neuroimmunomodulation 9(6):295-312
34. Hartmann S, Lucius R (2003) Modulation of host immune responses by nematode cystatins. Int J Parasitol 33(11):1291-1302
35. McFarlane E, Perez C, Charmoy M, Allenbach C, Carter KC, Alexander J, Tacchini-Cottier F (2008) Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect Immun 76(2):532-541
36. Wilson EH, Wille-Reece UF, Dzierszinski F, Hunter CA (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165:63-74
37. Herrera LA, Tato P, Molinari JL, Perez E, Dominguez H, Ostrosky-Wegman P (2003) Induction of DNA damage in human lymphocytes treated with a soluble factor secreted by Taenia solium metacestodes. Teratog Carcinog Mutagen Suppl 1:79-83
38. Tato P, Fernandez AM, Solano S, Borgonio V, Garrido EJ, Sepulveda J, Molinari JL (2004) A cysteine protease from Taenia solium metacestodes induce apoptosis in human CD4+ T-cells. Parasitol Res 92(3):197-204
39. White AC Jr, Robinson P, Kuhn R (1997) Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol 66:209-230
40. Liu ZG (2005) Molecular mechanism of TNF signaling and beyond. Cell Res 15(1):24-27
41. Xu G, Shi Y (2007) Apoptosis signaling pathways and lymphocyte homeostasis. Cell Res 17(9):759-771